High‐grade serous peritoneal cancer follows a high stromal response signature and shows worse outcome than ovarian cancer

In the era of personalized medicine, where transition from organ‐based to individualized genetic diagnosis takes place, the tailoring of treatment in cancer becomes increasingly important. This is particularly true for high‐grade, advanced FIGO stage serous adenocarcinomas of the ovary (OC), fallopi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacob, Francis, Marchetti, Rosa Lina, Kind, André B., Russell, Kenneth, Schoetzau, Andreas, Heinzelmann‐Schwarz, Viola A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782088/
https://www.ncbi.nlm.nih.gov/pubmed/33016563
http://dx.doi.org/10.1002/1878-0261.12811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782088/
https://www.ncbi.nlm.nih.gov/pubmed/33016563
http://dx.doi.org/10.1002/1878-0261.12811

Ejemplares similares